Safety and Outcomes With Combination Therapy With Sarilumab and Baricitinib for Severe COVID-19 Respiratory Infection in Cancer Patients

OBJECTIVES: This study aims to describe the clinical outcomes of combination therapy with sarilumab and baricitinib for severe novel Coronavirus-19 (COVID-19) infection in cancer patients. With this study, we aim to evaluate the role of expanded immunotherapy for severely ill patients with COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Velez, Ana Paula, Handley, Guy, Morison, Austin, Katzman, Ju Hee, kinkhova, Olga, Quiltz, Rod, Greene, John, Pasikhova, Yanina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566286/
https://www.ncbi.nlm.nih.gov/pubmed/37817417
http://dx.doi.org/10.1177/10732748231205864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566286/
https://www.ncbi.nlm.nih.gov/pubmed/37817417
http://dx.doi.org/10.1177/10732748231205864

Ejemplares similares